Search Results - "DiJoseph, J"

Refine Results
  1. 1

    Therapeutic potential of CD22-specific antibody-targeted chemotherapy using inotuzumab ozogamicin (CMC-544) for the treatment of acute lymphoblastic leukemia by DIJOSEPH, J. F, DOUGHER, M. M, ARMELLINO, D. C, EVANS, D. Y, DAMLE, N. K

    Published in Leukemia (01-11-2007)
    “…CMC-544 (inotuzumab ozogamicin) is a CD22-specific cytotoxic immunoconjugate of calicheamicin intended for the treatment of B-lymphoid malignancies. This…”
    Get full text
    Journal Article
  2. 2

    The oncofetal protein, 5T4, is a suitable target for antibody-guided anti-cancer chemotherapy with calicheamicin by BOGHAERT, E. R, SRIDHARAN, L, DOUGHER, M, DIJOSEPH, J. F, DAMLE, N. K, KHANDKE, K. M, ARMELLINO, D, RYAN, M. G, MYERS, K, HARROP, R, KUNZ, A, HAMANN, P. R, MARQUETTE, K

    Published in International journal of oncology (2008)
    “…The oncofetal protein, 5T4, is a tumor-associated protein displayed on the cell membrane of various carcinomas. This molecule is a promising target for…”
    Get full text
    Journal Article
  3. 3

    Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors by Zask, A., Gu, Y., Albright, J.D., Du, X., Hogan, M., Levin, J.I., Chen, J.M., Killar, L.M., Sung, A., DiJoseph, J.F., Sharr, M.A., Roth, C.E., Skala, S., Jin, G., Cowling, R., Mohler, K.M., Barone, D., Black, R., March, C., Skotnicki, J.S.

    Published in Bioorganic & medicinal chemistry letters (17-04-2003)
    “…Potent and selective bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors were synthesized by a novel convergent route. Selectivity and efficacy versus…”
    Get full text
    Journal Article
  4. 4

    The discovery of anthranilic acid-based MMP inhibitors. Part 2: SAR of the 5-position and P1(1) groups by Levin, J I, Chen, J, Du, M, Hogan, M, Kincaid, S, Nelson, F C, Venkatesan, A M, Wehr, T, Zask, A, DiJoseph, J, Killar, L M, Skala, S, Sung, A, Sharr, M, Roth, C, Jin, G, Cowling, R, Mohler, K M, Black, R A, March, C J, Skotnicki, J S

    Published in Bioorganic & medicinal chemistry letters (20-08-2001)
    “…A novel series of anthranilic acid-based inhibitors of MMP-1, MMP-9, MMP-13, and TACE was prepared and evaluated. Selective inhibitors of MMP-9, MMP-13, and…”
    Get full text
    Journal Article
  5. 5

    The discovery of anthranilic acid-based mmp inhibitors. Part 3: incorporation of basic amines by Levin, J.I, Chen, J.M, Du, M.T, Nelson, F.C, Wehr, T, DiJoseph, J.F, Killar, L.M, Skala, S, Sung, A, Sharr, M.A, Roth, C.E, Jin, G, Cowling, R, Di, L, Sherman, M, Xu, Z.B, March, C.J, Mohler, K.M, Black, R.A, Skotnicki, J.S

    Published in Bioorganic & medicinal chemistry letters (19-11-2001)
    “…Anthranilic acid derivatives bearing basic amines were prepared and evaluated in vitro and in vivo as inhibitors of MMP-1, MMP-9, MMP-13, and TACE. Piperazine…”
    Get full text
    Journal Article
  6. 6

    The effect of rapamycin on kidney function in the Sprague-Dawley rat by DiJoseph, J F, Sharma, R N, Chang, J Y

    Published in Transplantation (01-03-1992)
    “…The effects of rapamycin (RAPA) on kidney function and histology were investigated in the Sprague-Dawley rat and compared with cyclosporine. Drugs were…”
    Get more information
    Journal Article
  7. 7
  8. 8

    Therapeutic blood levels of sirolimus (rapamycin) in the allografted rat by DIJOSEPH, J. F, FLUHLER, E, ARMSRONG, J, SHARR, M, SEHGAL, S. N

    Published in Transplantation (27-10-1996)
    “…A study was conducted to determine the relationship among oral dose, trough whole blood levels, graft survival, and side effects in sirolimus-treated…”
    Get full text
    Journal Article
  9. 9

    The synthesis and biological activity of a novel series of diazepine MMP inhibitors by Levin, Jeremy I., DiJoseph, John F., Killar, Loran M., Sung, Amy, Walter, Thomas, Sharr, Michele A., Roth, Catherine E., Skotnicki, Jerauld S., Albright, J.Donald

    Published in Bioorganic & medicinal chemistry letters (06-10-1998)
    “…A novel series of diazepine-based hydroxamic acid inhibitors of MMP-1, MMP-9, and MMP-13 were prepared and evaluated both in vitro and in vivo. A novel series…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    The discovery of anthranilic acid-based MMP inhibitors. Part 1: SAR of the 3-position by LEVIN, Jeremy I, DU, Mila T, GUIXIAN JIN, COWLING, Rebecca, SKOTNICKI, Jerauld S, DIJOSEPH, John F, KILLAR, Loran M, SUNG, Amy, WALTER, Thomas, SHARR, Michele A, ROTH, Catherine E, MOY, Franklin J, POWERS, Robert

    Published in Bioorganic & medicinal chemistry letters (22-01-2001)
    “…A novel series of anthranilic acid-based inhibitors of MMP-1, MMP-9, and MMP-13 was prepared and evaluated both in vitro and in vivo. The most potent compound,…”
    Get full text
    Journal Article
  14. 14

    Renal effects of rapamycin in the spontaneously hypertensive rat by DiJoseph, J F, Mihatsch, M J, Sehgal, S N

    Published in Transplant international (01-03-1994)
    “…The effects of rapamycin (RAPA), administered at therapeutic doses, were investigated in the spontaneously hypertensive rat (SHR). Additionally, the…”
    Get more information
    Journal Article
  15. 15
  16. 16

    Gastric antisecretory and antiulcer effects of WHR1582A, a compound exerting alpha-2 adrenoceptor agonist activity by DiJoseph, J F, Eash, J R, Mir, G N

    “…The gastric antisecretory and antiulcer effects of a novel compound, [1-(2,-dimethylphenyl)-3-isobutoxyamidinourea]hydrochloride (WHR1582A), are described…”
    Get more information
    Journal Article
  17. 17
  18. 18

    Activated aluminum complex derived from solubilized antacids exhibits enhanced cytoprotective activity in the rat by DiJoseph, J F, Borella, L E, Mir, G N

    Published in Gastroenterology (New York, N.Y. 1943) (01-03-1989)
    “…Removing the buffering capacity of aluminum-containing antacids by acidification greatly increased their cytoprotective activity over the parent antacid…”
    Get more information
    Journal Article
  19. 19

    Dialysis tubing implant assay in the rat: A novel in vivo method for identifying inhibitors of matrix metalloproteinases by DiJoseph, John F., Sharr, Michele A.

    Published in Drug development research (01-04-1998)
    “…A novel model to assess the in vivo bioactivity of matrix metalloproteinase (MMP) inhibitors is described. A solution containing the target enzyme, either…”
    Get full text
    Journal Article
  20. 20

    Kidney dysfunction in the arthritic rat by Dijoseph, J F, Walter, T L, Hartman, D A, Carlson, R P

    “…Kidney function and histopathology were investigated in the adjuvant-induced arthritic rat. Rats injected with Mycobacterium butyricum exhibited symptoms of…”
    Get more information
    Journal Article